• 1
    Macedo-Souza LI, Kok F, Santos S, Amorim SC, Starling A, Nishimura A, et al. Spastic paraplegia, optic atrophy, and neuropathy is linked to chromosome 11q13. Ann Neurol 2005;57:730737.
  • 2
    Macedo-Souza LI, Kok F, Santos S, Licinio L, Lezirovitz K, Cavacana N, et al. Spastic paraplegia, optic atrophy, and neuropathy: new observations, locus refinement, and exclusion of candidate genes. Ann Hum Genet 2009;73:382387.
  • 3
    Moreira RO, Castro AP, Papelbaum M, Appolinário JC, Ellinger VC, Coutinho WF, et al. Translation into Portuguese and assessment of the reliability of a scale for the diagnosis of diabetic distal polyneuropathy [in Portuguese]. Arq Bras Endocrinol Metabol 2005;49:944950.
  • 4
    Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150154.
  • 5
    Al-Qattan MM. Assessment of the motor power in older children with obstetric brachial plexus palsy. J Hand Surg Br Eur 2003;28B:4649.
  • 6
    Cornblath DR. Research criteria for diagnosis of chronic inflamatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617618.
  • 7
    van der Meché FG, van Doorn PA, Meulstee J, Jennekens FG, Centre G-cgot DNRS. Diagnostic and classification criteria for the Guillain–Barré syndrome. Eur Neurol 2001;45:133139.
  • 8
    Graciani Z, Santos S, Macedo-Souza LI, Monteiro CB, Veras MI, Amorim S, et al. Motor and functional evaluation of patients with spastic paraplegia, optic atrophy, and neuropathy (SPOAN). Arq Neuropsiquiatr 2010;68:36.
  • 9
    Vallat JM, Tazir M, Magdelaine C, Sturtz F, Grid D. Autosomal-recessive Charcot–Marie–Tooth diseases. J Neuropathol Exp Neurol 2005;64:363370.
  • 10
    Frith JA, McLeod JG, Nicholson GA, Yang F. Peroneal muscular-atrophy with pyramidal tract features (hereditary motor and sensory neuropathy type-V)—a clinical, neurophysiological, and pathological study of a large kindred. J Neurol Neurosurg Psychiatry 1994;57:13431346.
  • 11
    Ippel EF, Wittebolpost D, Jennekens FGI, Bijlsma JB. Genetic heterogeneity of hereditary motor and sensory neuropathy type VI. J Child Neurol 1995;10:459463.
  • 12
    Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol 2009;8:654667.
  • 13
    Finsterer J, Loescher W, Quasthoff S, Wanschitz J, Auer-Grumbach M, Stevanin G. Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci 2012;318:118.
  • 14
    Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010;133:771786.
  • 15
    Shimazaki H, Takiyama Y, Ishiura H, Sakai C, Matsushima Y, Hatakeyama H, et al. A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55). J Med Genet 2012;49:777784.
  • 16
    Beetz C, Johnson A, Schuh AL, Thakur S, Varga RE, Fothergill T, et al. Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure. Proc Natl Acad Sci USA 2013;110:50915096.